Chiauranib (CS2164) is a first-in-class orally active multi-target inhibitor of tumor angiogenesis.Chiauranib potently inhibits the angiogenesis-related kinases (VEGFR1, VEGFR2, VEGFR3, PDGFRalpha and c-Kit), mitosis-related kinase Aurora B and chronic inflammation-related kinase CSF-1R. Chiauranib has strong anticancer activity.
Molekulargewicht:
435.47
Reinheit:
>99%
CAS Nummer:
[1256349-48-0]
Formel:
C27H21N3O3
Target-Kategorie:
VEGFR/PDGFR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten